Skip to content

Perception of Blood Sugar Variations During Physical Activity in Healthy Subjects and Type 1 Diabetes Patients

Perception of Blood Sugar Variations During Physical Activity in Healthy Subjects and Type 1 Diabetes Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05357534
Acronym
GLYSPORT
Enrollment
30
Registered
2022-05-03
Start date
2022-06-01
Completion date
2023-02-01
Last updated
2022-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes

Keywords

Type 1 Diabetes, blood sugar variations, physical activity

Brief summary

Type 1 diabetes is an autoimmune disease with absence of insulin secretion. Blood sugar is a physiological variable that reflets for blood glucose concentration. Blood sugar level fluctuates, especially during physical activity. Sports activity would increase insulin sensitivity, improve lifestyle and, by extension, promote glycemic balance. However, glycemic balance will be disturbed by physical activity with higher risk of hypoglycemia and hyperglycemia. Moreover, hypoglycemia and hyperglycemia will impact body functions. Perceptions of blood sugar variations during physical exercise and their influences on sports performance have not been studied, whether in type 1 diabetes patients or healthy subjects.

Detailed description

The aim of the study is to evaluate the perception of blood sugar variations in healthy subjects and type 1 diabetes patients during physical activity

Interventions

OTHERPhysical activity

Physical activity: 10 km run on a treadmill

Sponsors

Université de Reims Champagne-Ardenne
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Type 1 diabetics diagnosed more than 3 years ago and controlled (an HbA1c of less than 8%) for type 1 diabetes group * without diabetes for healkthy group * Male * Aged 18 to 65 * Body Mass Index less than 30 kg/m2 * regular running (at least 30 minutes per week and at least one 10-km run per year for the previous 2 years) * Agreeing to participate in the study

Exclusion criteria

* Physical injury * beta blockers treatment

Design outcomes

Primary

MeasureTime frameDescription
blood sugarDay 0Blood sugar evaluated in g/L via continuous blood glucose measurement
Feeling lucidityDay 0Lucidity, which is a symptom of hyperglycaemia and hypoglycaemia, assessed by visual analog scale (between not at all lucid to completely lucid
Feeling fatigueDay 0hydratation, which is a symptom of hyperglycaemia and hypoglycaemia, assessed by visual analog scale (between no feeling of dehydration to dehydrated
feeling hungryDay 0hungry, which is a symptom of hyperglycaemia and hypoglycaemia, assessed by visual analog scale (between no feeling of hunger to hungry
average speed per kilometer Sports performanceDay 0Sports performance evaluated by average speed per kilometer of the 10 km run on a treadmill
total running timeDay 0Sports performance evaluated by total running time of the 10 km run on a treadmill
average running speedDay 0Sports performance evaluated by average running speed of the 10 km run on a treadmill

Contacts

Primary ContactPhilippe JOLY, MCU-HDR
philippe.joly@univ-reims.fr0326918822
Backup ContactCoralie BARBE, MD
currs@univ-reims.fr0326918822

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026